Saturday, July 11, 2026

pharma · Hyperbilirubinemia

Mallinckrodt Pharmaceuticals

Mallinckrodt Pharmaceuticals clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Dublin, IE HQ
1867 Founded
2,708 Employees
EMA registrant Type
Company details
Status
Public
HQ
Dublin, IE
Founded
1867
Employees
2,708
Programs
1
Drugs
0
Patents
0
Intelligence · Clinical Programs

Mallinckrodt Pharmaceuticals projects

1 ClinicalTrials.gov programs sponsored by Mallinckrodt Pharmaceuticals.

Mallinckrodt Pharmaceuticals has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Stanate

    Mallinckrodt Pharmaceuticals Ireland Limited

    Hyperbilirubinemia

    phase 2 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Mallinckrodt Pharmaceuticals have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.